EDRS
PACB icon

Edmond de Rothschild (Suisse)’s Pacific Biosciences PACB Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$50K Buy
+5,560
New +$46.5K 0.02% 317
2015
Q4 		– Sell
-12,000
Closed -$44K – 428
2015
Q3 		$44K Sell
12,000
-14,000
-54% -$68.4K 0.01% 287
2015
Q2 		$150K Buy
+26,000
New +$150K 0.05% 181

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s PACB Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) opened a new position in Pacific Biosciences (PACB) in Q3 2016: 5,560 shares worth $50K. The stake represents 0.02% of the portfolio and ranks #317 among its holdings. This is a return to the name: Edmond de Rothschild (Suisse) previously reported a position in PACB as recently as Q3 2015.

Edmond de Rothschild (Suisse) first reported a position in PACB in Q2 2015 and has held it in 3 quarters since. The position peaked at $150K in Q2 2015. 128 funds tracked by Wall St. Rank hold PACB as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 5,560 shares of Pacific Biosciences worth $50K as of Q3 2016.
  • Pacific Biosciences was a new Edmond de Rothschild (Suisse) position in Q3 2016.
  • Pacific Biosciences made up 0.02% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #317 holding.
  • Edmond de Rothschild (Suisse) first reported a position in Pacific Biosciences in Q2 2015 and has held it in 3 quarters since.
  • Edmond de Rothschild (Suisse)'s Pacific Biosciences position peaked at $150K in Q2 2015.
  • 128 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.